Form4insider filings, from the source

SEC Form 5/A · accession 0001209191-16-099605

Lineage Cell Therapeutics, Inc. · LCTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Alfred D Kingsley
Officer — See Remarks · Director · 10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Feb 17, 2016 · 8:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, no par valueF1,F2Dec 1, 2015G6,500—D5,931,555D
Common Shares, no par valueF3Dec 1, 2015G55,800—D1,451,105IBy Greenbelt Corp.
Common Shares, no par valueholding———375,351IBy Greenway Partners, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Option to Purchase Common SharesF4$5.13holding————Jun 30, 2016Common Shares50,00050,000D
Option to Purchase Common SharesF5$4.60holding————Jun 30, 2017Common Shares50,00050,000D
Option to Purchase Common SharesF6$4.13holding————Jun 30, 2018Common Shares50,00050,000D
Option to Purchase Common SharesF7$3.11holding————Jun 30, 2019Common Shares50,00050,000D
Option to Purchase Common SharesF8$3.57holding————Jun 30, 2020Common Shares50,00050,000D

Explanation of responses